Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative chemotherapy versus surveillance in upper tract urothelial cancer
ISRCTN98387754Phase 3Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jun 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of gemcitabine, cisplatin and carboplatin in upper tract urothelial carcinoma (UTUC) (2 arms), sponsored by The Institute of Cancer Research. Primary endpoint: Disease-free survival. Started Jun 2012; status: completed.
02
Drugs
gemcitabinecisplatincarboplatin
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on ISRCTN98387754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98387754.